Showing results (191-200 of 4,494) with videos related to
Sort By:
Pageof 450
Advances in Therapy|May 8, 2020
A Phase II Study of Modified FOLFOX6 for Advanced Gastric Cancer Refractory to Standard TherapiesSeiichiro Mitani, Shigenori Kadowaki, Azusa Komori, et al.Advances in Therapy|May 8, 2020
Cetuximab Maintenance Therapy in Patients with Unresectable Wild-Type RAS and BRAF Metastatic Colorectal Cancer: A Single-Institute Prospective StudyTao Jiang, Hao Chen, Jianwei Zheng, et al.Advances in Therapy|September 3, 2021
Myths and Truths about Placebo Effect in Rehabilitation for Musculoskeletal PainGiovanni Iolascon, Antimo MorettiAdvances in Therapy|April 30, 2021
Strategies to Prolong Ketamine's Efficacy in Adults with Treatment-Resistant DepressionEric P McMullen, Yena Lee, Orly Lipsitz, et al.Advances in Therapy|August 21, 2021
Revisiting Treatment Options for Depressed Patients with Generalised Anxiety DisorderGuy M GoodwinAdvances in Therapy|July 22, 2015
Type 2 Diabetes Mellitus Patients' Healthcare Costs Related to Inpatient Hospitalizations: A Retrospective Administrative Claims Database StudyVishal Saundankar, Jeffrey Ellis, Elsie Allen, et al.Advances in Therapy|August 28, 2025
A New Ashwagandha Formulation (Zenroot™) Alleviates Stress and Anxiety Symptoms While Improving Mood and Sleep Quality: A Randomized, Double-Blind, Placebo-Controlled Clinical StudyManasvi Mahadevan, Kumarpillai Gopukumar, Ruchi Gupta, et al.Advances in Therapy|July 21, 2016
Additive Intraocular Pressure Lowering Effects of the Rho Kinase Inhibitor, Ripasudil in Glaucoma Patients Not Able to Obtain Adequate Control After Other Maximal Tolerated Medical TherapyShino Sato, Kazuyuki Hirooka, Eri Nitta, et al.Advances in Therapy|April 11, 2020
Distinct Serum and Vitreous Inflammation-Related Factor Profiles in Patients with Proliferative VitreoretinopathyYao Ni, Yingyan Qin, Zijing Huang, et al.Advances in Therapy|April 11, 2020
A Map of Racial and Ethnic Disparities in Influenza Vaccine Uptake in the Medicare Fee-for-Service ProgramLaura L Hall, Liou Xu, Salaheddin M Mahmud, et al.Pageof 450